摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

di-μ-chlorobis[chloro(dimethylphenylphosphine)platinum(II)] | 15699-79-3

中文名称
——
中文别名
——
英文名称
di-μ-chlorobis[chloro(dimethylphenylphosphine)platinum(II)]
英文别名
[(PtCl(μ-Cl)(PMe2Ph))2];[PtCl2(μ-Cl)2(PMe2Ph)2];[Pt2Cl2(μ-Cl)2(PMe2Ph)2];dichloroplatinum;dimethyl(phenyl)phosphane
di-μ-chlorobis[chloro(dimethylphenylphosphine)platinum(II)]化学式
CAS
15699-79-3
化学式
C16H22Cl4P2Pt2
mdl
——
分子量
808.27
InChiKey
ABJSMKJZDJKAOG-UHFFFAOYSA-J
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    铂(II)的电子中性烷氧基(有机)卡宾络合物的反应
    摘要:
    卡宾配合物顺式-[PtCl 2(PR 3){C(OR')(CH 2 R '')}](1; R 3 = Me 2 Ph或Et 3; R'= Me,Et或Pr n; R''= Me,Et或Ph)与CD 3 OD迅速反应生成顺式-[PtCl 2(PR 3){C(OR')(CD 2 R '' )}]],然后通过烷氧基交换缓慢生成顺式-[PtCl 2(PR 3){C(OCD 3)(CD 2 R'')}}。二甲胺通过质子提取反应形成[PtCl(PR 3)(NMe 2H){C(OR')CHR '' }]。卡宾配合物通过R'Cl消除与氯离子反应形成酰基[Pt 2(µ-Cl)2(PR 3)2(COCH 2 R'')2 ]。(1)的热解产生相同的产物。将这些反应与相关的阳离子卡宾配合物进行了比较。在Ag- [S(CF 3)O 3 ]存在下用PR 3处理(1)会导致阳离子卡宾配合物反式-[PtCl(PR 3)2
    DOI:
    10.1039/dt9790000690
  • 作为产物:
    参考文献:
    名称:
    Briggs, John R.; Crocker, Christopher; McDonald, Walter S., Journal of the Chemical Society, Dalton Transactions, 1982, p. 457 - 464
    摘要:
    DOI:
  • 作为试剂:
    描述:
    cis-[bis(dimethylphenylphosphane)dichlroplatinum(II)] 、 cis-[Me2Pt(PMe2Ph)2] 在 di-μ-chlorobis[chloro(dimethylphenylphosphine)platinum(II)] 作用下, 以 二氯甲烷 为溶剂, 生成 trans-[Pt(Me)Cl(PMe2Ph)2]
    参考文献:
    名称:
    铂(II)配合物中的烷基交换反应及其催化
    摘要:
    OT的symmetrisation反应[PTR的研究2大号2 ]与[PTX 2大号2 ]得到[PtXRL 2 ]的情况下(R = Me中,pH值,或C CME; L = PET 3,PME 3,PME 2 Ph或AsMe 3; X = Cl,I,NCS,NO 2或NO 3)。研究了反应速率和立体化学对取代基R,X和L的依赖性,并讨论了反应机理。的反应顺式- [氯铂酸2(PME 2 PH)2 ]与顺式- [PTME 2(PME2 Ph) 2 ]产生顺式-[PtClMe(PMe 2 Ph) 2 ]被[Pt 2 Cl 4(PMe 2 Ph) 2 ]催化,但在与顺式-[PtMe 2( PMe 2 Ph) 2 ]得到顺式-[Pt 2(μ-Cl) 2 Me 2(PMe 2 Ph) 2 ]。
    DOI:
    10.1039/dt9770001219
点击查看最新优质反应信息

文献信息

  • The co-ordination chemistry of 2-(diphenylphosphinoamino)pyridine †
    作者:Stephen M. Aucott、Alexandra M. Z. Slawin、J. Derek Woollins
    DOI:10.1039/b003294h
    日期:——
    2-(Diphenylphosphinoamino)pyridine, dppap [Ph2PNHpy], and over 40 illustrative examples of its complexes have been prepared. Monodentate, bidentate and bridging co-ordination of the neutral (and bidentate deprotonated ligand) has been demonstrated in a range of palladium, platinum and gold complexes. Ten demonstrative examples have been characterised by single crystal X-ray diffraction. Ph2PNHpy exists as hydrogen-bonded dimer pairs; cis-[PtCl(Ph2PNHpy-P,N)Ph2PNHpy-P}]Cl packs in hydrogen-bonded infinite chains; cis-[Pt(Ph2PNpy-P,N)2] and cis-[Pd(Ph2PNpy-P,N)2] are isomorphous. The structures of cis-[Pd(Ph2PNHpy-P,N)2][BF4]2, [AuCl(Ph2PNHpy-P)], [Pt(C8H12OMe)(Ph2PNpy-P,N)]·H2O illustrating hydrogen-bonding, cis-[PtCl(Ph2PNHpy-P,N)(PMe3)]Cl, cis-[PtCl(Ph2PNpy-P,N)(PMe3)] and cis-[PtCl(Ph2PNHpy-P,N)(P(OPh)3)]Cl are also reported.
    2-(二苯膦基)吡啶,dppap [Ph2PNHpy],以及超过40个示例性的其配合物已被制备。在一系列配合物中,示例了中性(以及双齿去质子化配体)的单齿、双齿和桥联配位方式。十个示范性例子通过单晶X射线衍射进行了表征。Ph2PNHpy以氢键结合的二聚体对形式存在;cis-[PtCl(Ph2PNHpy-P,N)Ph2PNHpy-P}]Cl通过氢键形成无限链;cis-[Pt(Ph2PNpy-P,N)2]和cis-[Pd(Ph2PNpy-P,N)2]是同构的。cis-[Pd(Ph2PNHpy-P,N)2][BF4]2、[AuCl(Ph2PNHpy-P)]、[Pt(C8H12OMe)(Ph2PNpy-P,N)]·H2O展示了氢键结合,cis-[PtCl(Ph2PNHpy-P,N)(PMe3)]Cl、cis-[PtCl(Ph2PNpy-P,N)(PMe3)]和cis-[PtCl(Ph2PNHpy-P,N)(P(OPh)3)]Cl的结构也被报道。
  • Preparations and properties of the and ylide complexes with palladium(II) and platinum(II) dichlorides
    作者:M. Toriuchi、G. Matsubayashi、H. Koezuka、T. Tanaka
    DOI:10.1016/s0020-1693(00)81991-x
    日期:1976.1
    All the complexes are demonstrated to have a trans-configuration around the metal atom. Infrared and 1H NMR spectra reveal that the coordination bond in the YS complexes is stronger than that in the YN ones, and that the platinum(H) complexes are more stable than the palladium(II) ones. In addition, the coordination abilities of both Ys and YN are shown to be weaker than those of ylides having a skeleton
    (II)和二氯化铂(H)与稳定的亚胺(PhC(O)Me 2 = Y S)或酰亚胺(PhC(O)Me 3 = Y N),MCl 2(L)(L')(中号,Lÿ小号,Y ñ ; L'= PPH 3 3,PPH 2中号ë,PPhMe 2)中制备。Y S和Y N的羰基伸缩带在形成复合物时移向高频,表明Y S或Y N的配位通过带负电荷的氮原子与属相连 已证明所有配合物在属原子周围均具有反式构型。红外和1 H NMR光谱显示,Y S配合物中的配位键比Y N配合物中的配位键强,并且(H)配合物比(II)配合物更稳定。另外,显示出Y s和Y N的配位能力都比具有骨架的伊利德的配位能力弱。
  • Synthesis, fluxional behaviour, and oxidative-addition reactions of some µ-alkylthio-diplatinum(<scp>II</scp>) complexes
    作者:Michael P. Brown、Richard J. Puddephatt、Clive E. E. Upton
    DOI:10.1039/dt9760002490
    日期:——
    A series of complexes cis-[Pt2X2(PMe2Ph)2(µ-SMe)2](X = Cl, I, Me, or Ph) and cis-[Pt2X2(PMe2Ph)2(µ-SEt)2](X = Cl or Me) has been prepared. The complexes undergo a fluxional process thought to involve inversion at the bridging sulphur atoms. and the rate is strongly dependent on the group X. Reactions of the complexes with X = Me or Ph with methyl iodide are complicated and involve oxidative-additi
    一系列配合物顺式-[Pt 2 X 2(PMe 2 Ph)2(µ-SMe)2 ](X = Cl,I,Me或Ph)和顺式-[Pt 2 X 2(PMe 2 Ph)2已经制备了(μ-SEt)2 ](X = Cl或Me)。络合物经历了通量过程,该过程涉及在桥连的原子上发生转化。X = Me或Ph与碘甲烷的络合物的反应非常复杂,并且涉及氧化加成还原消除序列,从而得到单体有机络合物作为最终产物。
  • Synthesis and characterization of mono-and bi-nuclear palladium(II) and platinum(II) complexes containing acetamidine ligands
    作者:Anshu Singhal、Vimal K. Jain
    DOI:10.1139/v96-230
    日期:1996.11.1

    The reactions of [M2Cl2(μ-Cl)2(PR3)2] with acetamidines in 1:2 stoichiometry afforded mononuclear complexes, [MCl2ArNHC(Me)NAr}(PR3)] (I) (M = Pd or Pt; R3 = Et3, Bu3, Me2Ph, MePh2; Ar = Ph or 4-MeC6H4 (tol)). Treatment of [M2Cl4(PR3)2] with Li[ArNC(Me)NAr] under anerobic conditions gave acetamidino-bridged binuclear complexes, [M2Cl2(μ-ArNC(Me)NAr)2(PR3)2] (II). The reaction of [Pd2(μ-Cl)23-allyl)2] with Ag[ArNC(Me)NAr] gave acetamidino-bridged allyl complexes [Pd2(μ-ArNC(Me)NAr)23-allyl)2] (III). All the complexes were characterized by elemental analyses and NMR (1H, 31P, 195Pt) spectroscopy. The mononuclear complexes (I) exist in two isomeric forms differing in the coordination of monodentate acetamidine ligand. The 31P and 195Pt NMR data on binuclear complexes (II) indicate that there is no significant Pt–Pt interaction. The allyl complexes (III) (allyl = C3H5) exhibit formation of all three possible isomers, whereas methallyl (allyl = C4H7) derivatives exist only in one configuration. Key words: palladium, platinum, acetamidine, NMR (1H, 31P, 195Pt), mononuclear complexes, binuclear complexes.

    [M2Cl2(μ-Cl)2(PR3)2]与乙酰胺在1:2的化学计量比下反应,生成单核配合物,[MCl2ArNHC(Me)NAr}(PR3)] (I) (M = Pd或Pt;R3 = Et3,Bu3,Me2Ph,MePh2;Ar = Ph或4-MeC6H4 (tol))。将[M2Cl4(PR3)2]与Li[ArNC(Me)NAr]在无氧条件下反应,得到乙酰胺桥联的双核配合物,[M2Cl2(μ-ArNC(Me)NAr)2(PR3)2] (II)。[Pd2(μ-Cl)23-allyl)2]与Ag[ArNC(Me)NAr]反应,生成乙酰胺桥联的烯丙基配合物,[Pd2(μ-ArNC(Me)NAr)23-allyl)2] (III)。所有配合物均通过元素分析和NMR (1H,31P,195Pt)光谱表征。单核配合物(I)存在两种异构形式,其区别在于单齿乙酰胺配体的配位方式。双核配合物(II)的31P和195Pt NMR数据表明不存在显著的Pt-Pt相互作用。烯丙基配合物(III) (烯丙基 = C3H5) 显示出所有三种可能的异构体形成,而甲基烯丙基 (烯丙基 = C4H7) 衍生物只存在一种构型。关键词:、乙酰胺、NMR (1H,31P,195Pt)、单核配合物、双核配合物。
  • Preparation and spectroscopic properties of electroneutral alkoxy(organo)carbene complexes of platinum(<scp>II</scp>) and the crystal and molecular structure of cis-[benzyl(ethoxy)carbene]dichloro(dimethylphenylphosphine)platinum(<scp>II</scp>)
    作者:Gordon K. Anderson、Ronald J. Cross、Ljubica Manojlović-Muir、Kenneth W. Muir、Robin A. Wales
    DOI:10.1039/dt9790000684
    日期:——
    cis-[PtX2LC(OR′)(CH2R)}], has been prepared by reaction of the halide-bridged dimer [Pt2X4L2](X = Cl, Br, or l; L = PMe2Ph or PEt3) with monosubstituted acetylenes RCCH(R = Ph, Me, or Et) and alcohols R′OH (R′= Me, Et, or Prn). The complexes have been characterised analytically, by 1H and 31P n.m.r. and i.r. spectroscopy, and by X-ray analysis of a typical member of the series. Crystals of the title complex are monoclinic
    (II)的一系列电子中性烷氧基(有机)卡宾配合物,顺式-[PtX 2 L C(OR')(CH 2 R)}]的制备,是通过卤化物桥联的二聚体[Pt 2 X 4 L 2 ](X = Cl,Br或l; L = PMe 2 Ph或PEt 3),带有单取代的乙炔RC CH(R = Ph,Me或Et)和醇R'OH(R'= Me, Et或Pr n)。已通过1 H和31 P nmr和红外光谱以及X进行了分析表征系列的典型成员的X射线分析。标题配合物的晶体为单斜晶体,空间群P 2 1 / n,a = 15.084(2),b = 8.4,19(3),c = 15.801(3)Å,β= 92.93(2)°,且Z =4。该结构已通过重原子法求解,并通过全矩阵最小二乘法对2166个已校正吸收的衍射强度数据进行修正,使R = 0.036。晶体由具有顺方形平面几何形状的离散分子构成。选择的键长为:Pt–P 2.240(3),Pt–Cl(反式至P)2
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫